Yan-Qiu Du

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Immunotherapy is a novel treatment for advanced non-small cell lung cancer (NSCLC) patients. Immunotherapy includes two main broad classes of therapeutic vaccines and immune checkpoint inhibitors, as well as cytokines, biological response modifiers and cellular therapy. The present systematic review and meta-analysis aims to evaluate the efficacy and safety(More)
  • 1